MediciNova, Inc.

MNOV Healthcare Biotechnology

MediciNova, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $409,700.00, down 59.0% from fiscal 2023. In the quarter to June 2026, revenue grew 240.6%, EPS grew 28.6% and free cash flow grew 16.8%, each against the same quarter a year earlier.

1.42 0.03 −2.07%
Market cap
$71.4M
P/E
0.0×
Fwd P/E
−5.0×
Dividend yield
—
F-score
n/a
Altman Z
−4.10
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(25.56%) (26.24%) (25.50%) (24.26%)

+8 more TTM periods

ROA
(23.83%) (24.64%) (23.65%) (22.73%)
ROIC
(62.48%) (66.84%) (77.01%) (73.31%)
Return on Tangible Assets
(46.81%) (46.76%) (44.11%) (40.58%)
Average Days of Receivables
0.00 149.95 0.00 0.00
Free Cash Flow per Share
(0.19) (0.19) (0.20) (0.20)
Free Cash Flow
(9.12) (9.51) (9.81) (9.73)
Other line items

Show all line items

Columns are period end dates